- Credits - Section Writer: Dr. Om J Lakhani - Section Editor: Dr. Om J Lakhani - Contributions from: - Dr. Om J Lakhani > Download the new "Notes in Endocrinology" App > Apple iOS- https://shrtm.nu/H45n > Android - https://shrtm.nu/SyBG - Q. What is the definition of Osteoporosis? - It is a disease characterized by - Low bone mass - Microarchitectural disruption - Increase skeletal fragility - Leading to an increase in fracture risk - WHO defines it as T score <-2.5 This is edited by Dr. Om J Lakhani - Q. Give the WHO diagnostic criteria for osteoporosis? - Normal T score >-1.0 - Osteopenia – T score -1.0 to -2.5 - Osteoporosis – T score <-2.5 - Severe osteoporosis- T score < -2.5 + Fragility fracture - **Q. What are the diagnostic criteria based on AACE 2020 guidelines ?** - 1. T-score − 2.5 or below in the lumbar spine, femoral neck, total proximal femur, or 1/3 radius - 2. Low-trauma spine or hip fracture (__regardless of bone mineral density__) - 3. T-score between − 1.0 and − 2.5 and a fragility fracture of the proximal humerus, pelvis, or distal forearm - 4. T-score between − 1.0 and − 2.5 and high FRAX® (or if available, TBS-adjusted FRAX®) fracture probability based on country-specific thresholds - Q. What are T-score and Z-score? - The T-score is the number of standard deviations of the BMD from the normal value of a young adult - The Z-score represents the number of standard deviations of the BMD from the normal value of the age, sex, race/ethnicity matched control subjects - Q. When to use T-score and when to use Z-score? - T-score is used for the standard diagnosis of osteoporosis in postmenopausal and elderly men - Z-score is used to diagnose low bone mass or vulnerable bones in premenopausal women or young men. - Q. What Z score cutoff is used for diagnosis of osteoporosis in Young premenopausal women? - If the Z score is < -2.0 the lady is said to have "low bone mass". Osteoporosis may not be a suitable term to use for premenopausal women, but a low bone mass term may be used as a substitute to "osteoporosis" and means the same diagnostically - In premenopausal women - the search for the secondary cause is a must - **Q. Is FRAX for India available ?** - Yes - Please use the link https://www.sheffield.ac.uk/FRAX/tool.aspx?country=51 - **Q. What is the cut-off for treatment based on the FRAX score ?** - FRAX shows 10 years probability of fracture - The indications for intervention are : - 3% for hip fracture or - ≥ 20% for major osteoporotic fracture - **Q. If a patient has a fragility fracture, does she need a DEXA scan for the diagnosis of Osteoporosis ?** - No - A fragility fracture is diagnostic of osteoporosis - It does not need a DEXA scan to prove the diagnosis - **Q. What is a fragility fracture ?** - "A fragility fracture is usually a fracture sustained from force similar to a fall from a standing position or less that would not have occurred in healthy bone, excepting fractures of the skull, face, fingers, and toes." - Q. What are the current screening guidelines for osteoporosis by NOF? - All women >/= 65 years - All men >/= 70 years - All between ages 50-69 years with risk factors for osteoporosis - Adults having fractures after 50 years - Those with low bone mass and RA - Those with low bone mass on Gc of dose predinisolone equivalents >/= 5 mg for >/= 3 months - Q. What is the mortality rate following a hip fracture in postmenopausal women? - 2-year mortality rate in postmenopausal women following a hip fracture is 12-20% - Q. Enlist the risk factors for Osteoporosis? - Advancing age - Rheumatoid arthritis - Current cigarette smoking - Excessive alcohol consumption - Glucocorticoid use - Family history of hip fracture - Rheumatoid arthritis - Previous fragility fracture - Other secondary causes - Hypogonadism - Early menopause - Malabsorption - IBD - CLD - Primary hyperparathyroidism - Q. What is the indication for lateral X-ray in the elderly? - All men >80 years and women >70 years with BMD T score <-1.0 - All men 70-79 years and women 65-69 years with T score <-1.5 - Postmenopausal women and men >50 years with - Historical height loss > 4cm (>1.5 inch) - Prospective height loss >2 cm (0.8 inch) - Low trauma fracture - Recent or ongoing Glucocorticoid use - Q. What are the preferred screening tests? - DEXA - Q. What are the sites for DEXA for screening? - Hip and spine - In the elderly Hip alone is enough - Q. Which hip should be measured, right or left? - Ideally at baseline both hips should be measured - Q. Which specific sites are to be measured? - 1. Total Hip - 2. Femoral neck - 3. Lumbar spine L1-L4 - Q. When is BMD repeated if the initial BMD does not show osteoporosis? - Women > 65 years - Initial BMD <-2.0 – 2.5 at any site or having a risk factor for ongoing bone loss- every 2 years - Initial BMD <1.5 to -2.0 at any site – every 3-5 years - Initial BMD <1.0-  1.5 with no other risk factor – every 10-15 years - Q. What are the arguments in favor of screening for osteoporosis? - BMD has a definite link with fracture risk - Treatment is available which can prevent fracture - Knowledge of risk will help improve compliance with lifestyle and treatment - It is a common disease with a high impact on morbidity and mortality - Screening tests are easily available - Q. What are the arguments against screening? - BMD is not the only criteria that define the risk of fracture - If BMD Is normal- does it rule out the risk of fracture? - Cost of screening - Single measurement of BMD less important than serial measurements - Q. For what duration of glucocorticoid use, should DEXA be done? - For post-menopausal women, if glucocorticoids are given for >3 months or anticipated to be given for >3 months, a DEXA must be done at baseline without fail - **Osteoporotic fracture risk assessment** - Q. What are the methods for assessment of osteoporosis fracture risk? - FRAX - BMD measurement - Assessment of bone microarchitecture (beyond BMD) - Q.  How is bone microarchitecture assessed? - HR pQCT - Tetracycline labeled transiliac bone biopsy - Micro MRI - High-resolution MRI - Trabecular bone score – indirect marker - \[\[FRAX]] - Q. In FRAX, the Risk of fracture is expressed as absolute risk or relative risk? - It is expressed as an absolute risk of fracture in the next 10 years - Q. FRAX is applicable for age group patients? - Patients between the age of 40-90 years - Q. Which are the factors considered in FRAX? - Age - Sex - BMI - Parental fracture of the hip - Previous fracture (A previous fracture denotes more accurately a previous fracture in adult life occurring spontaneously, or a fracture arising from trauma which, in a healthy individual, would not have resulted in a fracture. Enter yes or no (see also notes on risk factors) - Current smoking - Alcohol - >/= 3 units/day - Rheumatoid arthritis - Glucocorticoid use – Prednisolone >5 mg for >3 months - Secondary osteoporosis - Femoral neck BMD - Q. Which are factors included in secondary osteoporosis? - Type 1 diabetes - Hypogonadism - Premature menopause - PHPT - CLD - Malabsorption - Malnutrition - Uncontrolled hyperthyroidism - Osteogenesis imperfecta - Q. What will the results give you? - 10-year risk of - Major osteoporotic fracture - Hip fracture - Each in percentage - Q. Is FRAX for India available? - Yes - Please use the link https://www.sheffield.ac.uk/FRAX/tool.aspx?country=51 - Q. What is the bias of basing treatment based on FRAX? - Treatment based on FRAX will treat more older patients with higher T scores compared to younger patients with the lower T scores - Q. What are the limitations of FRAX? - Limited to 4 ethnicities - Only takes into account Hip BMD and not lumbar or other BMD - Other cases it may underestimate the risk (see below) - All regions data not available - Q. FRAX is used for which ethnicities? - Black - Hispanic - Asian - Caucasian - Q. In which patients do FRAX underestimate the fracture risk? - Type 2 diabetics - Multiple fractures - Family history of non-hip fracture - High dose Gc >7.5 mg - Severe vertebral fractures - Low Lumbar BMD with normal hip BMD - Q. Overall does FRAX underestimate or overestimate fracture risk? - Overall, FRAX underestimates future fracture risk - Also fall events and the risk of falls are not directly captured by FRAX - Q. Which other fracture risk calculator also takes risk of fall into account? - Garvan Fracture risk calculator - **Measurement of BMD** - Q. What are the methods for measurement of  BMD? - DEXA - Peripheral DEXA - pQCT - Quantitative ultrasound - Q. How much does fracture risk increase for every 1 SD fall in BMD T score? - 2 times increase risk - Q. Where is peripheral QCT measured? - Forearm - Calcaneus - Finger - Q. What are the advantages and disadvantages of pDEXA (Peripheral DEXA)? - Advantage- Portable - Disadvantage - Cannot be used for classifying based on the WHO model - Cannot be used for follow-up treatment - Q. What parameters are measured using quantitative ultrasound (QUS)? - It does not measure BMD - But measures - SOS – speed of sound - Stiffness Index- SI - Quantitative ultrasound index - Broadband ultrasound attenuation - Q. Is QUS a good fracture predictor? - Yes - Q. What are the disadvantages of QUS? - WHO criteria are not based on QUS - It cannot be used to monitor therapy as it changes very slowly - It cannot be used for treatment decisions as no trials are based on it - **pQCT ** - Q. What is measured in pQCT? - Volumetric BMD – in mg/cm3 - DEXA measure in g/cm2 - Q. What is the biggest advantage of pQCT? - Measurement of Cortical and trabecular fractions of the bone - It is mainly a research tool at present since it is more expensive and more radiation is used - Q. Can it be used for FRAX calculation? - Yes hip QCT adjusted for BMD can be entered into the FRAX data - **Newer techniques ** - Q. What is \[\[TBS (Trabecular bone score)]]? - It is the trabecular bone score - It is a software addition to the DEXA machine - It gives the texture of the bone  which correlates with the bone microarchitecture - It can be used with FRAX - Q. How do you interpret TBS? - High TBS values suggest a more homogenous texture of bone suggesting good bone microarchitecture and lower fracture risk - Low TBS suggests a higher fracture risk - This has been validated in several studies - Q. What are the interpretation based on exact values? - TBS - ≥1.350 → Normal - 1.200-1.350 → Partially degraded microarchitecture - ≤1.200 → degraded microarchitecture - Q. In which cases is TBS particularly useful? - It is a useful addition to FRAX, especially in cases where FRAX is likely to underestimate the fracture risk - Examples are \[\[Type 2 Diabetes mellitus]] and \[\[Primary hyperparathyroidism (PHPT)]] - Q. What is the advantage of HR- pQCT? - Cell tells about the bone microarchitecture - micro MRI can give similar information - Q. What is Hip structural analysis? - It takes data obtained from the DEXA to look at hip parameters - It measures Hip axis length which correlates with fracture risk  and other parameters like Neck shaft angle etc - **Skeletal site to measure** - Q.  Which are common sites for DEXA? - ISCD recommends - Hip - Lumbar - For assessment commonly - However, if they cannot be assessed – a distal radius can be used - Lumbar is less useful in the elderly who have degenerative disc disease and aortic calcification - Q. Which are the 2 most important non-BMD risk factors for fracture? - Advancing age - Previous fracture References: 1. Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, Harris ST, Hurley DL, Kelly J, Lewiecki EM, Pessah-Pollack R. American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis—2020 update. Endocrine Practice. 2020 May 1;26:1-46